issue cover v7i12

Previous issue | Next issue | Archive | Cover PDF   

Volume 7 (12); 2016

Research Paper

AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells
Sherif Abdelhamed, Keisuke Ogura, Satoru Yokoyama, Ikuo Saiki, Yoshihiro Hayakawa
J. Cancer 2016; 7(12): 1579-1586. doi:10.7150/jca.14713
[Abstract] [Full text] [PDF] [PubMed] [PMC]

African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer
Robert Wieder, Basit Shafiq, Nabil Adam
J. Cancer 2016; 7(12): 1587-1598. doi:10.7150/jca.16012
[Abstract] [Full text] [PDF] [PubMed] [PMC]

MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients
Yong-Qiang Zhang, Wei-Ya Wang, Jian-Xin Xue, Yan Xu, Ping Fan, Bennett Adam Caughey, Wei-Wei Tan, Gui-Qun Cao, Li-Li Jiang, You Lu, Kang Zhang, Xun Hu
J. Cancer 2016; 7(12): 1610-1620. doi:10.7150/jca.14923
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer
Gabriela Figueroa-González, Verónica García-Castillo, Jossimar Coronel-Hernández, Eduardo López-Urrutia, Sonia León-Cabrera, Luis E Arias-Romero, LI Terrazas, Miriam Rodríguez-Sosa, Alma Delia Campos-Parra, Eduardo Zúñiga-Calzada, Cesar Lopez-Camarillo, Fermín Morales-González, Nadia J Jacobo-Herrera, Carlos Pérez-Plasencia
J. Cancer 2016; 7(12): 1632-1644. doi:10.7150/jca.13123
[Abstract] [Full text] [PDF] [PubMed] [PMC]

High Stoichiometry Phosphorylation of Talin at T144/T150 or S446 Produces Contrasting Effects on Calpain-mediated Talin Cleavage and Cell Migration
Youjun Li, Xiaoyong Luo, Yang Sun, Zhenyi Cui, Yizhou Liu, Rushi Liu, Xiangrong Guo
J. Cancer 2016; 7(12): 1645-1652. doi:10.7150/jca.14192
[Abstract] [Full text] [PDF] [PubMed] [PMC]

MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1
Wei-Yang Tao, Chun-Yang Wang, Yong-Hui Sun, Yong-Hui Su, Da Pang, Guo-Qiang Zhang
J. Cancer 2016; 7(12): 1653-1662. doi:10.7150/jca.14762
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China
Ji-Feng Feng, Xun Yang, Sheng Chen, Qiang Zhao, Qi-Xun Chen
J. Cancer 2016; 7(12): 1663-1667. doi:10.7150/jca.15216
[Abstract] [Full text] [PDF] [PubMed] [PMC]

An Integrated Analysis of the Genome-Wide Profiles of DNA Methylation and mRNA Expression Defining the Side Population of a Human Malignant Mesothelioma Cell Line
Myung-Chul Kim, Na-Yon Kim, Yu-Ri Seo, Yongbaek Kim
J. Cancer 2016; 7(12): 1668-1679. doi:10.7150/jca.15423
[Abstract] [Full text] [PDF] [PubMed] [PMC]

GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects
Ying Wang, Jing He, Tian-Jiao Ma, Wei Lei, Feng Li, Han Shen, Zhen-Ya Shen
J. Cancer 2016; 7(12): 1680-1693. doi:10.7150/jca.15494
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Lentivirus-mediated Knockdown of HDAC1 Uncovers Its Role in Esophageal Cancer Metastasis and Chemosensitivity
Min Song, Gang He, Yan Wang, Xueli Pang, Bo Zhang
J. Cancer 2016; 7(12): 1694-1700. doi:10.7150/jca.15086
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma
Siyi Wanggou, Chengyuan Feng, Yuanyang Xie, Linrong Ye, Feiyifan Wang, Xuejun Li
J. Cancer 2016; 7(12): 1701-1710. doi:10.7150/jca.15486
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer
Ha Yeon Lee, In Gyu Hwang, Song-Ee Park, Moon Jin Kim, Se Hoon Park, Jung Hun Kang, Young Saing Kim, Sung Yong Oh, Young-Woong Won, Soon Il Lee, Jun Ho Ji, Kyong-Choun Chi
J. Cancer 2016; 7(12): 1711-1715. doi:10.7150/jca.15598
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma
Yi-Ying Lee, Tung-Bo Chao, Ming-Jen Sheu, Yu-Feng Tian, Tzu-Ju Chen, Sung-Wei Lee, Hong-Lin He, I-Wei Chang, Chung-Hsi Hsing, Ching-Yih Lin, Chien-Feng Li
J. Cancer 2016; 7(12): 1716-1723. doi:10.7150/jca.15667
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Increased Prevalence of Esophageal Cancer in Areas with High Levels of Nickel in Farm Soils
Chien-Pang Lee, Yen-Hsin Lee, Ie-Bin Lian, Che-Chun Su
J. Cancer 2016; 7(12): 1724-1730. doi:10.7150/jca.15441
[Abstract] [Full text] [PDF] [PubMed] [PMC]

XPG Gene Polymorphisms Contribute to Colorectal Cancer Susceptibility: A Two-Stage Case-Control Study
Rui-Xi Hua, Zhen-Jian Zhuo, Jinhong Zhu, Shao-Dan Zhang, Wen-Qiong Xue, Jiang-Bo Zhang, Hong-Mei Xu, Xi-Zhao Li, Pei-Fen Zhang, Jing He, Wei-Hua Jia
J. Cancer 2016; 7(12): 1731-1739. doi:10.7150/jca.15602
[Abstract] [Full text] [PDF] [PubMed] [PMC]

MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers
Ji Zhou, Huaxin Duan, Yu Xie, Yichong Ning, Xing Zhang, Na Hui, Chunqing Wang, Jian Zhang, Jianlin Zhou
J. Cancer 2016; 7(12): 1740-1746. doi:10.7150/jca.15620
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients
Danian Dai, Bo Chen, Bin Wang, Hailin Tang, Xing Li, Zhiping Zhao, Xuan Li, Xiaoming Xie, Weidong Wei
J. Cancer 2016; 7(12): 1747-1754. doi:10.7150/jca.15776
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Short Research Communication

Differential Roles of Carboxylated and Uncarboxylated Osteocalcin in Prostate Cancer Growth
Yoshikazu Hayashi, Tomoyo Kawakubo-Yasukochi, Akiko Mizokami, Hiroshi Takeuchi, Seiji Nakamura, Masato Hirata
J. Cancer 2016; 7(12): 1605-1609. doi:10.7150/jca.15523
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Review

Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
Jung Hoon Kim, Bum Jun Kim, Hyeong Su Kim, Jung Han Kim
J. Cancer 2016; 7(12): 1599-1604. doi:10.7150/jca.16208
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?
Samy L Habib, Noor Y Al-Obaidi, Maciej Nowacki, Katarzyna Pietkun, Barbara Zegarska, Tomasz Kloskowski, Wojciech Zegarski, Tomasz Drewa, Edward A. Medina, Zhenze Zhao, Sitai Liang
J. Cancer 2016; 7(12): 1621-1631. doi:10.7150/jca.14747
[Abstract] [Full text] [PDF] [PubMed] [PMC]